Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Trial Profile

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Docetaxel (Primary) ; Mitoxantrone; Prednisone
  • Indications Prostate cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 11 Oct 2016 Results of retrospective post-hoc analysis presented at the 41st European Society for Medical Oncology Congress.
    • 05 Mar 2010 Results of retrospective analyses presented at ASCO Genitourinary Cancers Symposium 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top